What is Functional Fluidics?
Functional Fluidics operates as a CLIA-certified diagnostic laboratory that has carved out a specialized niche in the assessment of red blood cell health. The organization is primarily recognized for its proprietary assays and contract research services, which serve a diverse clientele ranging from pharmaceutical giants to academic research institutions. By focusing on Sickle Cell Disease, the company provides essential biomarkers that facilitate both drug development and clinical patient care. Furthermore, their international footprint, highlighted by a dedicated research center in Nigeria, demonstrates a commitment to addressing global health disparities and expanding their diagnostic reach within Sub-Saharan Africa.
How much funding has Functional Fluidics raised?
Functional Fluidics has raised a total of $134K across 1 funding round:
Debt
$134K
Debt (2021): $134K with participation from PPP
Key Investors in Functional Fluidics
PPP
Public-Private Partnership
What's next for Functional Fluidics?
With this late-stage financing, Functional Fluidics is strategically positioned to scale its diagnostic infrastructure and broaden the application of its proprietary assays. The company is expected to prioritize the expansion of its clinical research partnerships, aiming to solidify its biomarkers as the industry gold standard. Future growth initiatives will likely focus on enhancing operational capacity at their international research facilities and deepening their integration into the global pharmaceutical drug development pipeline. As the firm matures, the focus will shift toward long-term sustainability and the widespread adoption of their diagnostic protocols in clinical settings worldwide.
See full Functional Fluidics company page
